]>
IRCT138804172134N1 IRCT 2009-12-29 Arak University of Medical Sciences The effect of Alhagi Pseudalhagi distillate on ureteral stone expulsion The effect of Alhagi Pseudalhagi distillate on ureteral stone expulsion 2009-09-23 anticipated 100 Complete https://irct.ir/trial/1754 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. 1-2 Ureteral stone. Intervention 1: The control group receive Hydrochlorothiazide (25 mg/day), Tamsulosin (0.4 mg/day), Diclofenac sodium suppository (100 mg PRN), and Tramadol inj. (50 mg IM PRN). Intervention 2: The intervention group receive Hydrochlorothiazide tablets (25 mg/day), Tamsulosin capsules (0.4 mg/day), Diclofenac sodium suppository (100 mg PRN), Tramadol inj. (50 mg IM PRN), and 150 ml/day Alhagi Pseudalhagi distillate from "Padina Natural Products, Mashhad" in 3 divided doses.
public Dr. Ali Cyrus
Department of Surgery, Vali-Asr Hospital, Vali-Asr Square
Arak Iran (Islamic Republic of) +98 86 1222 1041 cyrus@arakmu.ac.ir Arak University of Medical Sciences scientific Dr. Ali Cyrus
Department of Surgery, Vali-Asr Hospital, Vali-Asr Square
Arak Iran (Islamic Republic of) +98 86 1222 1041 cyrus@arakmu.ac.ir Arak University of Medical Sciences Iran (Islamic Republic of) Inclusion criteria: having ureteral stones  6 mm, not severe hydronephrosis, age more than 20 yr and less than 60 yr, no signs of UTI or fever according to physical findings and urine analysis, no known renal diseases according to history and preliminary laboratory exams, no mandatory restriction of fluids due to an underlying disease, no bilateral ureteral stones, not having a single kidney, no known allergic reaction to Alhagi Pseudalhagi distillate or gum, not being pregnant, and body weight between 50 to 100 kg. Exclusion criteria: patients' reluctance to continue participating in the study, no follow up visits, progressive hydronephrosis during follow up, occurrence of fever or UTI during follow up, repeated bouts of unbearable ureteral colics during follow up, allergic reactions or complications due to the treatment. 20 years 60 years Both N20.1 Calculus of ureter Treatment - Drugs Treatment - Drugs The control group receive Hydrochlorothiazide (25 mg/day), Tamsulosin (0.4 mg/day), Diclofenac sodium suppository (100 mg PRN), and Tramadol inj. (50 mg IM PRN). The intervention group receive Hydrochlorothiazide tablets (25 mg/day), Tamsulosin capsules (0.4 mg/day), Diclofenac sodium suppository (100 mg PRN), Tramadol inj. (50 mg IM PRN), and 150 ml/day Alhagi Pseudalhagi distillate from "Padina Natural Products, Mashhad" in 3 divided doses. Ureteral stone passage. Timepoint: 2 and 4 weeks after commencement of therapy. Method of measurement: According to patients' report. Time to stone passage. Timepoint: 2 and 4 weeks after commencement of therapy. Method of measurement: by asking the patients. Arak University of Medical Sciences Approved 2008-10-29 Ethic committee of Arak University of Medical Sciences Pardis Complex, Basij Square, Enghelab Square, Taleghani Ave. Arak Iran (Islamic Republic of)